Christopher Wilke
Christopher Wilke
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, laryngeal disorder, neoplasm, otorhinolaryngologic disease, respiratory system disorder, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2026-04-16 | NCT02128906 |